NRXP

NRXP

USD

NRX Pharmaceuticals Inc. Common Stock

$2.450-0.220 (-8.240%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$2.670

High

$2.700

Low

$2.440

Volume

0.08M

Company Fundamentals

Market Cap

58.2M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.49M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.12Current $2.450High $6.01

Related News

Analyst Upgrades

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals with a Buy and maintains $34 price target.

View more
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target
GlobeNewswire

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

ONE-D is the first reported protocol to achieve remission from treatment-resistant depression with a single day of treatment, using an FDA-cleared device.HOPE is one of the first Ampa deployments nationwide and is now

View more
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
Analyst Upgrades

Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $47

Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals with a Buy and raises the price target from $46 to $47.

View more
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $47
Analyst Upgrades

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals with a Buy and maintains $34 price target.

View more
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target